articleimg-1
Oct 27, 2020

First COVID-19 patient treated with Remdesivir produced in Hungary leaves hospital

In total, 19 patients have so far received Remdesivir manufactured by Hungarian pharma company Richter Gedeon.

 

A 75 year old woman, the first COVID-19 patient to be treated with Remdesivir produced in Hungary, has been released from hospital.

The Budapest Semmelweis University said the diabetic patient, admitted to hospital with serious pneumonia on October 14, immediately received a combined therapy that included doses of Remdesivir. The therapy had significantly improved her condition. The patient is now convalescing in her home.

In total, 19 patients have so far received Remdesivir manufactured by Hungarian pharma company Richter Gedeon.

Remdesivir, a virus inhibitor, is given to COVID-19 patients hospitalized with a serious condition. Clinical trials of Richter’s Remdesivir in Hungary started in mid-October, with all four medical universities of the country participating. The drug was approved by the US Food and Drug Administration on October 22.

Photo credit: Portfolio